Article metrics

Download PDFPDF

1396 TriTCE CPI: a novel trispecifc T cell engager platform with integrated PD-1/PD-L1 checkpoint inhibition engineered for the treatment of immunosuppressed tumors

 

Online download statistics by month:

Online download statistics by month: November 2023 to May 2024

AbstractFullPdf
Nov 2023150013
Dec 20234808
Jan 20243702
Feb 20242404
Mar 20244004
Apr 20243404
May 20246008
Total393043